Oral biofilm inhibitor

US10307342B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10307342-B2
Application numberUS-201515505411-A
CountryUS
Kind codeB2
Filing dateAug 21, 2015
Priority dateAug 22, 2014
Publication dateJun 4, 2019
Grant dateJun 4, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

There is provided an oral biofilm inhibitor having an exceptional inhibitory effect on oral biofilm formation. It is an oral biofilm inhibitor comprising a curable composition containing an antimicrobial agent, wherein a compressive strength of a cured product formed by curing the composition is 150 MPa or less, and a content of the antimicrobial agent is 0.001 to 3% by weight. An oral biofilm inhibitor thus obtained is used for inhibiting biofilm formation in an oral cavity by applying a curable composition containing an antimicrobial agent to a dental defect site for allowing the composition to cure at the dental defect site, and then disintegrating the cured composition.

First claim

Opening claim text (preview).

The invention claimed is: 1. An oral biofilm inhibitor consisting of a curable composition containing cetylpyridinium chloride in paste form and which is at least one of a hydraulic composition, a photocurable composition or a thermosetting composition, wherein a compressive strength of a cured product formed by curing the composition is 10 MPa or less, and a content of the cetylpyridinium chloride is 0.001 to 3% by weight. 2. The oral biofilm inhibitor according to claim 1 , used for inhibiting biofilm formation in an oral cavity by applying the curable composition containing the cetylpyridinium chloride to a dental defect site for allowing the composition to cure at the dental defect site, and then disintegrating the cured composition. 3. The oral biofilm inhibitor according to claim 2 , wherein the curable composition is again applied to the site where the cured composition has been disintegrated. 4. An oral biofilm inhibitor kit comprising a curable composition and cetylpyridinium chloride in paste form and which is at least one of a hydraulic composition, a photocurable composition or a thermosetting composition, wherein a compressive strength of a cured product formed by curing an oral biofilm inhibitor is 10 MPa or less, and the curable composition and the cetylpyridinium chloride are blended for use such that a content of the cetylpyridinium chloride in the oral biofilm inhibitor comes to be 0.001 to 3% by weight. 5. An oral biofilm inhibitor kit comprising a curable composition in paste form which is at least one of a hydraulic composition, a photocurable composition or a thermosetting composition and a liquid agent containing water as a main component, wherein at least one of the curable composition and the liquid agent containing water as a main component comprises the cetylpyridinium chloride, a compressive strength of a cured product formed by curing the oral biofilm inhibitor is 10 MPa or less, and the curable composition and the liquid agent are blended for use such that a content of the cetylpyridinium chloride comes to be 0.001 to 3% by weight. 6. A method for producing an oral biofilm inhibitor comprising a curable composition containing cetylpyridinium chloride according to claim 1 , comprising blending the curable composition and the cetylpyridinium chloride such that a content of the cetylpyridinium chloride in the oral biofilm inhibitor comes to be 0.001 to 3% by weight. 7. A method for producing an oral biofilm inhibitor comprising a curable composition containing cetylpyridinium chloride according to claim 2 , comprising blending the curable composition and the cetylpyridinium chloride such that a content of the cetylpyridinium chloride in the oral biofilm inhibitor comes to be 0.001 to 3% by weight. 8. A method for producing an oral biofilm inhibitor comprising a curable composition containing cetylpyridinium chloride according to claim 3 , comprising blending the curable composition and the cetylpyridinium chloride such that a content of the cetylpyridinium chloride in the oral biofilm inhibitor comes to be 0.001 to 3% by weight.

Assignees

Inventors

Classifications

  • Antibacterial agents · CPC title

  • Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title

  • Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish · CPC title

  • comprising natural or synthetic resins · CPC title

  • A61K6/80Primary

    Preparations for artificial teeth, for filling teeth or for capping teeth · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10307342B2 cover?
There is provided an oral biofilm inhibitor having an exceptional inhibitory effect on oral biofilm formation. It is an oral biofilm inhibitor comprising a curable composition containing an antimicrobial agent, wherein a compressive strength of a cured product formed by curing the composition is 150 MPa or less, and a content of the antimicrobial agent is 0.001 to 3% by weight. An oral biofilm …
Who is the assignee on this patent?
Nat Univ Corporation Okayama Univ
What technology area does this patent fall under?
Primary CPC classification A61K6/80. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).